Avivagen Profile

0.58
CAD 0.03  5.45%
71%
49%

Avivagen Summary

Avivagen (VIV) is traded on TSX Venture Exchange in Canada. It is located in 100 Sussex Drive and employs 16 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 21.15 M. Avivagen has 33.57 M outstanding shares of which 4.5 K shares are at this time shorted by private and institutional investors with about 0.38 days to cover all short positions. AVIVAGEN INC has accumulated about 3.07 M in cash with (4.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Check Avivagen Probability Of Bankruptcy

Avivagen Target Price Odds Analysis

Odds Below 0.58HorizonTargetOdds Above 0.58
60.48%30 days 0.58 39.30%
Based on normal probability distribution, the odds of Avivagen to move above current price in 30 days from now is about 39.3% (This Avivagen probability density function shows the probability of Avivagen Stock to fall within a particular range of prices over 30 days) .

Avivagen Risk Profiles

Avivagen Key Fundamentals

Avivagen Against Markets

Avivagen Current Ratings

Avivagen 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
3 
Chance of
Financial Distress (0 to 100%)
25 
Equity ratings for Avivagen are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Avivagen, Inc. develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animals own health defenses. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen, Inc. in May 2012. Avivagen operates under Drug Manufacturers - Major classification in Canada and traded on TSX Venture Exchange. It employs 16 people. more
NameAvivagen
CEO and President and DirectorCameron GroomeView All
Macroaxis Advice
InstrumentCanada Stock View All
Business Address100 Sussex Drive
Foreign Associate  USA
ExchangeTSX Venture Exchange
SectorHealthcare
BenchmarkDOW
Websitewww.avivagen.com
Phone613 949 8164
CurrencyCAD - Canadian Dollar

Did you try this?

Run Portfolio Reporting Now

   

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
All  Next Launch Portfolio Reporting

Avivagen Directors

Avivagen Corporate Directors

David Hankinson Executive Director
Louis Hui Director - Business Development
David Allan Director
Also please take a look at World Market Map. Please also try CEO Directory module to screen ceos from public companies around the world.
Search macroaxis.com